Publication | Open Access

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial

Hematological MalignancyLymphoid NeoplasiaOncologyImmunologyHematologyClinical TrialsObinutuzumab Versus ChlorambucilPharmacotherapyMedicinePhase 3Health Sciences